Russell Investments Group, Ltd. Novo Cure LTD Transaction History

Russell Investments Group, Ltd.

  • $70.2 Billion
  • Q1 2025

A detailed history of Russell Investments Group, Ltd. transactions in Novo Cure LTD stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 6,529 shares of NVCR stock, worth $121,047. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,529
Previous 1,158 463.82%
Holding current value
$121,047
Previous $34,000 241.18%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$17.82 - $30.19 $95,711 - $162,150
5,371 Added 463.82%
6,529 $116,000
Q4 2024

Feb 13, 2025
SELL
$14.54 - $33.41 $31,042 - $71,330
-2,135 Reduced 64.83%
1,158 $34,000
Q3 2024

Nov 13, 2024
SELL
$15.61 - $23.34 $129,266 - $193,278
-8,281 Reduced 71.55%
3,293 $51,000
Q2 2024

Aug 08, 2024
SELL
$11.83 - $24.05 $1.4 Million - $2.85 Million
-118,708 Reduced 91.12%
11,574 $198,000
Q1 2024

May 08, 2024
BUY
$12.42 - $17.29 $1.15 Million - $1.6 Million
92,771 Added 247.32%
130,282 $2.04 Million
Q4 2023

Feb 05, 2024
SELL
$11.13 - $15.78 $319,920 - $453,580
-28,744 Reduced 43.38%
37,511 $560,000
Q3 2023

Nov 13, 2023
SELL
$16.15 - $42.35 $200,421 - $525,563
-12,410 Reduced 15.78%
66,255 $1.07 Million
Q2 2023

Aug 10, 2023
SELL
$40.29 - $82.51 $303,907 - $622,372
-7,543 Reduced 8.75%
78,665 $3.26 Million
Q1 2023

May 09, 2023
BUY
$56.44 - $118.81 $2.68 Million - $5.64 Million
47,493 Added 122.67%
86,208 $5.18 Million
Q4 2022

Feb 08, 2023
BUY
$63.98 - $85.37 $27,767 - $37,050
434 Added 1.13%
38,715 $2.84 Million
Q3 2022

Nov 04, 2022
BUY
$67.99 - $89.57 $103,276 - $136,056
1,519 Added 4.13%
38,281 $2.94 Million
Q2 2022

Jul 29, 2022
BUY
$56.6 - $89.9 $5,546 - $8,810
98 Added 0.27%
36,762 $2.64 Million
Q1 2022

May 05, 2022
BUY
$60.15 - $84.52 $36,871 - $51,810
613 Added 1.7%
36,664 $3.07 Million
Q4 2021

Jan 21, 2022
BUY
$75.08 - $121.99 $39,341 - $63,922
524 Added 1.47%
36,051 $2.85 Million
Q3 2021

Nov 08, 2021
BUY
$116.17 - $194.55 $84,339 - $141,243
726 Added 2.09%
35,527 $4.12 Million
Q2 2021

Aug 04, 2021
SELL
$130.4 - $225.58 $6.39 Million - $11.1 Million
-49,018 Reduced 58.48%
34,801 $7.76 Million
Q1 2021

May 10, 2021
BUY
$124.11 - $190.17 $1.41 Million - $2.17 Million
11,386 Added 15.72%
83,819 $10.9 Million
Q4 2020

Feb 08, 2021
BUY
$112.16 - $174.14 $3.97 Million - $6.16 Million
35,378 Added 95.47%
72,433 $12.6 Million
Q3 2020

Nov 09, 2020
SELL
$58.05 - $111.31 $1.62 Million - $3.11 Million
-27,916 Reduced 42.97%
37,055 $4.07 Million
Q2 2020

Aug 05, 2020
SELL
$57.2 - $74.41 $408,808 - $531,808
-7,147 Reduced 9.91%
64,971 $3.81 Million
Q1 2020

May 06, 2020
BUY
$57.05 - $95.75 $2.12 Million - $3.55 Million
37,113 Added 106.02%
72,118 $4.93 Million
Q4 2019

Jan 29, 2020
SELL
$68.3 - $93.8 $251,753 - $345,746
-3,686 Reduced 9.53%
35,005 $2.98 Million
Q3 2019

Nov 01, 2019
BUY
$61.86 - $97.8 $58,395 - $92,323
944 Added 2.5%
38,691 $2.85 Million
Q2 2019

Aug 09, 2019
SELL
$42.22 - $63.23 $13,721 - $20,549
-325 Reduced 0.85%
37,747 $2.3 Million
Q1 2019

May 13, 2019
BUY
$31.96 - $56.12 $1.15 Million - $2.02 Million
35,917 Added 1666.68%
38,072 $1.8 Million
Q4 2018

Feb 11, 2019
SELL
$28.72 - $52.63 $203,136 - $372,251
-7,073 Reduced 76.65%
2,155 $71,000
Q2 2018

Aug 08, 2018
SELL
$19.85 - $32.0 $274,128 - $441,920
-13,810 Reduced 59.94%
9,228 $289,000
Q1 2018

May 11, 2018
SELL
$19.3 - $23.65 $34,045 - $41,718
-1,764 Reduced 7.11%
23,038 $502,000
Q3 2017

Nov 07, 2017
BUY
$18.05 - $21.75 $447,676 - $539,443
24,802
24,802 $492,000

Others Institutions Holding NVCR

# of Institutions
266
Shares Held
79.4M
Call Options Held
970K
Put Options Held
118K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.95B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email